Dissecting HDAC3-mediated tumor progression
Open Access
- 27 October 2008
- journal article
- editorial
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 7 (10) , 1581-1583
Abstract
Commentary to:HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signalingCassandra A. Godman, Rashmi Joshi, Brendan R. Tierney, Emily Greenspan, Theodore P. Rasmussen, Hsin-wei Wang, Dong-Guk Shin, Daniel W. Rosenberg, Charles GiardinaKeywords
This publication has 15 references indexed in Scilit:
- HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signalingCancer Biology & Therapy, 2008
- HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21Molecular Biology of the Cell, 2008
- Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage ControlMolecular Cell, 2008
- Drosophila Histone Deacetylase-3 Controls Imaginal Disc Size through Suppression of ApoptosisPLOS Genetics, 2008
- HDACs and HDAC inhibitors in colon cancerEpigenetics, 2008
- Histone deacetylase 3 represses p15INK4b and p21WAF1/cip1 transcription by interacting with Sp1Biochemical and Biophysical Research Communications, 2006
- Dietary Components Modify Gene Expression: Implications for CarcinogenesisThe Journal of Nutrition, 2005
- The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancerNature Medicine, 2004
- Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cellsOncogene, 2004
- Duration of Nuclear NF-κB Action Regulated by Reversible AcetylationScience, 2001